YSP Torixib 90mg Tab

Manufacturer
Y.S.P. Industries (M) Sdn. Bhd.

Registraction Number
MAL24026034AZ



Contents

• Active Ingredient: Etoricoxib 90 /mg per tablet — a selective COX 2 inhibitor with analgesic, anti inflammatory, and antipyretic effects
• Dosage Form: Film-coated tablet, in strips of 10 × 10 tablets per box
• Other Ingredients: Typical excipients according to Y.S.P. specifications (exact details not publicly disclosed)

• Treatment of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis—typically at doses of 60–90 /mg once daily, with 90 /mg used for enhanced effect in some patients
• Management of acute gouty arthritis (short-term use), and acute pain such as primary dysmenorrhoea or pain following minor dental surgery (up to 8 days) — 90 /mg is used for minor dental pain, while gout often requires 120 /mg daily (but Torixib is only available in 90 /mg strength)

• Dosage:
  • Rheumatoid arthritis, ankylosing spondylitis: 60–90 /mg once daily; minimum effective dose is 60 /mg; 90 /mg may offer additional benefit
  • Osteoarthritis: 30–60 /mg once daily; 90 /mg generally not recommended
  • Acute gouty arthritis: short-term use; 120 /mg once daily (Torixib 90 /mg not covering full dose but may be used if 120 /mg unavailable)
  • Minor dental pain: use 90 /mg once daily for up to 8 days
• Administration: Take orally with or without food, preferably at a fixed time—swallow whole; do not chew or crush
• Duration: Use for shortest effective period, especially for acute pain; osteoporosis or chronic conditions should be regularly reviewed to minimize long-term exposure